Adam Logal
Finanzdirektor/CFO bei OPKO HEALTH, INC.
Vermögen: 218 580 $ am 30.04.2024
Profil
Mr. Adam E.
Logal is a Chairman at Xenetic Biosciences, Inc. and a CFO, Treasurer, Chief Accounting Officer & SVP at OPKO Health, Inc. He is on the Board of Directors at Bio-Reference Laboratories, Inc. and OPKO Biologics Ltd.
Mr. Logal was previously employed as an Independent Director by VBI Vaccines, Inc., a Finance Director, Secretary, Treasurer & CAO by eXegenics, Inc., and a Chief Financial & Accounting Officer by Nabi Biopharmaceuticals.
He also served on the board at SciVac Therapeutics, Inc.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
OPKO HEALTH, INC.
0,03% | 29.02.2024 | 179 164 ( 0,03% ) | 218 580 $ | 30.04.2024 |
31.03.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Adam Logal
Unternehmen | Position | Beginn |
---|---|---|
OPKO HEALTH, INC. | Finanzdirektor/CFO | 31.03.2014 |
BIO-REFERENCE LABORATORIES INC | Direktor/Vorstandsmitglied | 20.08.2015 |
XENETIC BIOSCIENCES, INC. | Vorsitzender | 14.08.2017 |
OPKO Biologics Ltd.
OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | Direktor/Vorstandsmitglied | 01.04.2014 |
Ehemalige bekannte Positionen von Adam Logal
Unternehmen | Position | Ende |
---|---|---|
VBI VACCINES INC. | Direktor/Vorstandsmitglied | 01.10.2018 |
eXegenics, Inc. | Finanzdirektor/CFO | 13.06.2007 |
Nabi Biopharmaceuticals
Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | Finanzdirektor/CFO | 01.01.2007 |
SciVac Therapeutics, Inc. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
OPKO HEALTH, INC. | Health Services |
VBI VACCINES INC. | Health Technology |
XENETIC BIOSCIENCES, INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
Nabi Biopharmaceuticals
Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | Health Technology |
eXegenics, Inc. | Health Technology |
Bio-Reference Laboratories, Inc.
Bio-Reference Laboratories, Inc. Medical/Nursing ServicesHealth Services Bio-Reference Laboratories, Inc. engages in the provision testing and related services to physicians, clinics, hospitals, long-term care facilities, employers, government units, and correctional institutions. It offers a list of chemical diagnostic tests, including blood and urine analysis, blood chemistry, hematology, services, serology, radio-immuno analysis, toxicology, pap smears, tissue pathology and other tissue analysis. The firm focuses on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional health care. The company was founded by Marc D. Grodman in 1981 and is headquartered in Elmwood Park, NJ. | Health Services |
SciVac Therapeutics, Inc. | Health Technology |
OPKO Biologics Ltd.
OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | Health Technology |